가임력 보존의 현재와 앞으로 나아갈 길 = Fertility preservation in women: where we are now and the path we need to take

다국어 초록 (Multilingual Abstract)

Background: In its short history, reproductive medicine has achieved many fertility-related milestones, including: the arrival of in vitro fertilization in the late 1970s, the development of intracytoplasmic sperm injection in the early 1990s, the first ovarian transplant a decade ago, and the first livebirth after uterine transplantation in 2014.
This paper provides a brief overview of the indications and methods, as well as future perspectives, available for fertility preservation.
Current Concepts: More women are undergoing fertility preservation for medical or social reasons.
Fertility preservation aids cancer patients in retaining the ability to procreate. Despite the high survival rate of malignancies in young patients, chemotherapy and whole abdominal irradiation have cytotoxic effects on reproductive organs. Cancer treatments can significantly reduce a patient’s reproductive capacity and thus result in irreversible infertility. Early ovarian failure is also a common by-product of additional cancer treatment, bone marrow transplantation, or autologous transplantation. The current options for fertility preservation in cancer patients include cryopreservation (of embryos, oocytes, and ovarian tissue) and gonadotropic-releasing hormone agonist treatment (before and during chemotherapy). Fertility preservation is a means for female cancer patients to preserve their fertility and delay childbearing. Fertility preservation can also aid women who wish to delay childbearing for personal reasons. Since the indications for fertility preservation are different for each patient, individualized treatment strategies should be employed depending on the patient’s situation.
Discussion and Conclusion: Health professionals must inform women who are undergoing cancer treatments or purposefully delaying childbearing about the risks of decreased fertility. Appropriate fertility preservation options must be provided for these female patients.

참고문헌 (Reference)

1 Gellert SE, "Transplantation of frozen-thawed ovarian tissue : an update on worldwide activity published in peerreviewed papers and on the Danish cohort" 35 : 561-570, 2018

2 Fujimoto A, "The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer" 31 : 1189-1194, 2014

3 Winship AL, "The importance of DNA repair for maintaining oocyte quality in response to anti-cancer treatments, environmental toxins and maternal ageing" 24 : 119-134, 2018

4 Vanni VS, "Safety of fertility treatments in women with systemic autoimmune diseases(SADs)" 18 : 841-852, 2019

5 Howlader N, "SEER Cancer Statistics Review, 1975-2014" National Cancer Institute 2017

6 Hershlag A, "Return of fertility after autologous stem cell transplantation" 77 : 419-421, 2002

7 Skinner MK, "Regulation of primordial follicle assembly and development" 11 : 461-471, 2005

8 Black KZ, "Prevalence of preterm, low birthweight, and small for gestational age delivery after breast cancer diagnosis : a population-based study" 19 : 11-, 2017

9 Chang YS, "Pregnancy and its outcome by in vitro fertilization of human oocytes and embryo transfer" 29 : 354-361, 1986

10 Palermo G, "Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte" 340 : 17-18, 1992

11 Rienzi L, "Oocyte, embryo and blastocyst cryopreservation in ART : systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance" 23 : 139-155, 2017

12 Jacobson MH, "Menses resumption after cancer treatmentinduced amenorrhea occurs early or not at all" 105 : 765-772, 2016

13 Nicosia SV, "Gonadal effects of cancer therapy in girls" 55 : 2364-2372, 1985

14 Kim H, "Fertility preservation for patients with breast cancer : The Korean Society for Fertility Preservation clinical guidelines" 44 : 181-186, 2017

15 Kitajima M, "Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis" 93 : 685-691, 2011

16 Chung K, "Emergency IVF versus ovarian tissue cryopreservation : decision making in fertility preservation for female cancer patients" 99 : 1534-1542, 2013

17 Oktay K, "Efficiency of oocyte cryopreservation : a meta-analysis" 86 : 70-80, 2006

18 Feigin E, "Cancer in female adolescents" Nova Science Publishers 103-138, 2008

19 Diedrich K, "Cancer and fertility : strategies to preserve fertility" 22 : 232-248, 2011

20 Steptoe PC, "Birth after the reimplantation of a human embryo" 2 : 366-, 1978

21 Letourneau JM, "Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer" 118 : 1933-1939, 2012